- There are several risk factors for dementia, including type 2 diabetes.
- A new study reports that semaglutide — the active ingredient in type 2 diabetes and weight loss GLP-1 medications Ozempic and Wegovy — may help lower dementia risk in people with type 2 diabetes.
- Researchers say semaglutide targets several dementia risk factors, in addition to being anti-inflammatory, which could explain this benefit.
Written by Corrie Pelc on June 24, 2025 — Fact checked by Jill Seladi-Schulman, Ph.D.
Call us at (888)-243-6602 to discuss how we can help keep your loved one safe and happy at home.